Correlation Between AbbVie and Morningstar Unconstrained

Can any of the company-specific risk be diversified away by investing in both AbbVie and Morningstar Unconstrained at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AbbVie and Morningstar Unconstrained into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between AbbVie Inc and Morningstar Unconstrained Allocation, you can compare the effects of market volatilities on AbbVie and Morningstar Unconstrained and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AbbVie with a short position of Morningstar Unconstrained. Check out your portfolio center. Please also check ongoing floating volatility patterns of AbbVie and Morningstar Unconstrained.

Diversification Opportunities for AbbVie and Morningstar Unconstrained

-0.22

Correlation Coefficient

AbbVie  Morningstar Unconstrained

Very good diversification

The 3 months correlation between AbbVie and Morningstar is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding AbbVie Inc and Morningstar Unconstrained Allo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Morningstar Unconstrained and AbbVie is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AbbVie Inc are associated (or correlated) with Morningstar Unconstrained. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Morningstar Unconstrained has no effect on the direction of AbbVie i.e., AbbVie and Morningstar Unconstrained go up and down completely randomly.

Pair Corralation between AbbVie and Morningstar Unconstrained

Given the investment horizon of 90 days AbbVie Inc is expected to under-perform the Morningstar Unconstrained. In addition to that, AbbVie is 1.45 times more volatile than Morningstar Unconstrained Allocation. It trades about -0.18 of its total potential returns per unit of risk. Morningstar Unconstrained Allocation is currently generating about 0.13 per unit of volatility. If you would invest  1,060  in Morningstar Unconstrained Allocation on March 1, 2024 and sell it today you would earn a total of  18.00  from holding Morningstar Unconstrained Allocation or generate 1.7% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	95.45%
Values	Daily Returns

AbbVie Inc  vs.  Morningstar Unconstrained Allo

AbbVie Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days AbbVie Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's fundamental drivers remain fairly stable which may send shares a bit higher in June 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Morningstar Unconstrained

Risk-Adjusted Performance

2 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Morningstar Unconstrained Allocation are ranked lower than 2 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Morningstar Unconstrained is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with AbbVie and Morningstar Unconstrained

The main advantage of trading using opposite AbbVie and Morningstar Unconstrained positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AbbVie position performs unexpectedly, Morningstar Unconstrained can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Morningstar Unconstrained will offset losses from the drop in Morningstar Unconstrained's long position.

The idea behind AbbVie Inc and Morningstar Unconstrained Allocation pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .